Inactivation of the TGF-β Type II Receptor in Lung Cancer Cells
Author Information
Author(s): Hougaard S, Nørgaard P, Abrahamsen N, Moses H L, Spang-Thomsen M, Skovgaard Poulsen H
Primary Institution: Section for Radiation Biology, The Finsen Center, University Hospital of Copenhagen
Hypothesis
The study aims to examine the cause of absent type II receptor expression in small cell lung cancer cell lines.
Conclusion
The lack of type II receptor mRNA in most small cell lung cancer cell lines is not commonly due to mutations or hypermethylation.
Supporting Evidence
- 16 out of 21 small cell lung cancer cell lines showed very weak RII RNA expression.
- No mutations were detected in the poly-A tract of the RII gene.
- A GG to TT base substitution was found in one cell line that did not express RII.
Takeaway
Researchers looked at why some lung cancer cells don't have a certain receptor that usually helps control cell growth, and they found that it's not because of common mutations.
Methodology
Northern blot analysis and Southern blot analysis were used to examine RII RNA expression and mutations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website